J. Toms

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke ( RIGHT-2 ) : an ambulance-based , randomised , sham-controlled , blinded , phase 3 trial

Peter J. Godolphin, P. Sandercock, C. Anderson, 2019 .

Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial

Michael E. Williamson, Richard E. McCormick, J. Canny, 2020, Lancet.

The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial

James R. Robinson, M. Orr, P. Brownson, 2019, The Lancet.

POS1046 DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM

A. Blauvelt, A. Menter, H. Sofen, 2022, Annals of the Rheumatic Diseases.

Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

Karen E. Williams, Raquel Siqueira Nóbrega, Christopher G. Smalley, 2021, The Lancet. Global health.

Impact of Evidence‐Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study

Sarah S Richtering, Y. Liu, M. Woodward, 2019, Journal of the American Heart Association.

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

P. Sandercock, C. Anderson, P. Rothwell, 2019, Lancet.

Cancelled operations: a 7‐day cohort study of planned adult inpatient surgery in 245 UK National Health Service hospitals

Cheng Soon Ong, Paul J Cripps, Bassey D. Nkanang, 2018, British journal of anaesthesia.

Digital Rocks: Developing An Emerging Technology Through To A Proven Capability Deployed In The Business

J. Fredrich, Nathaniel Lane, D. Lakshtanov, 2014 .